Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    " October 25, 2010":" November 24, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Withdrawn Depot Contraception With and Without Lopinavir/Ritonavir
Condition: HIV Infection
Intervention: Drug: DMPA
2 Completed Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir plus one nucleoside;   Drug: lopinavir /ritonavir plus two nucleosides
3 Unknown  Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infection
Intervention: Drug: Hydroxychloroquine
4 Withdrawn A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium
Condition: HIV Infections
Interventions: Drug: Maraviroc/Dapivirine Gel;   Drug: Dapivirine Vaginal Gel;   Drug: Maraviroc Vaginal Gel;   Drug: Matching Placebo Gel
5 Completed Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Condition: HIV
Intervention:
6 Completed Acceptability Study of Vaginal Films for HIV Prevention
Conditions: HIV Infections;   Anti-Infective Agents
Intervention: Other: No intervention (not applicable)
7 Active, not recruiting Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
Condition: HIV
Intervention: Drug: Raltegravir
8 Completed The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
Conditions: HIV Infections;   Depression;   Mild Cognitive Impairment
Interventions: Drug: raltegravir single dose;   Drug: ginkgo biloba multiple dose
9 Terminated Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
Condition: HIV
Intervention: Drug: CYT107
10 Completed
Has Results
Addressing Psychosocial Needs and HIV Risk in Indian MSM
Conditions: HIV/STI Risk;   HIV/STI Incidence
Intervention: Behavioral: Behavioral intervention
11 Unknown  Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)
Conditions: HIV Infection;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Protease Inhibitor;   Drug: Standard-of-care Antiretroviral therapy
12 Enrolling by invitation IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents
Conditions: ADHD;   HIV
Intervention:
13 Completed Effects of Cash Transfer for the Prevention of HIV in Young South African Women
Condition: HIV
Interventions: Behavioral: monthly cash transfer payments for attending school;   Behavioral: B--No cash transfers
14 Completed
Has Results
Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir (TDF);   Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTI);   Drug: Famotidine (FAM)
15 Completed Vaginal Innate Immunity in Normal and HIV-Infected Women
Conditions: HIV;   Pregnancy
Intervention: Other: Vaginal lavage specimen
16 Completed Post-Exposure Prophylaxis in Health Care Workers
Condition: Human Immunodeficiency Virus
Intervention: Drug: emtricitabine/tenofovir disoproxil fumarate
17 Completed Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Rifampin;   Drug: Rifabutin
18 Unknown  Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3
Condition: HIV-1 Infection
Intervention: Drug: Maraviroc
19 Completed
Has Results
Will Having Alcohol Treatment Improve Functioning?
Conditions: HIV;   Alcoholism
Interventions: Drug: Naltrexone, 50mg, once per day for 4 months;   Other: Sugar pill, 50mg, once per day for 4 months
20 Completed IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites
Conditions: IRIS;   HIV
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.